This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Timothy Michael Braden and the Oscillating Fluidized Bed Oligonucleotide Synthesizer
Introduction
Timothy Michael Braden is an inventor associated with Greenwood, Indiana, and Eli Lilly and Company. His patent work addresses solid-phase oligonucleotide synthesis, focusing on fluidizing and mixing resin beads to improve reagent contact and washing.
Latest Patents
Braden is named on 1 patent: “Oscillating Fluidized Bed Oligonucleotide Synthesizer.” The invention describes a filter reactor that builds an oligonucleotide on solid-phase resin. During synthesis, a protecting group is removed from the oligonucleotide’s 5′ position, and an activated amidite solution is introduced. The solution moves up and down through the resin bed, mixing the beads and promoting reaction at the 5′ position.
The process includes reactions such as deblocking, coupling, oxidation, sulfurization, and capping. Fluidizing or mixing the resin helps reagents contact it throughout the bed. After reactions, reagents drain through the filter bottom before washing. The design aims to maintain a flat, channel-free resin bed, while a spray cone or other distributor spreads reagents and wash solvents evenly across its surface.
The patent also describes ways to use solvents and reagents more efficiently. Washing can be divided into segments, with cleaner portions collected for use in a later synthesis cycle. Integrated multi-pass washing can further reduce solvent use, and excess deblocking reagent solution can be recycled between phosphoramidite cycles.
Career Highlights
Braden’s disclosed patent work connects process engineering with oligonucleotide synthesis. Its reactor design focuses on consistent reagent contact, controlled fluid movement, and opportunities to reuse wash solvents and deblocking reagents. The patent lists Eli Lilly and Company as the company associated with his work.
Collaborations
Martin D. Johnson and Luke P. Webster are identified as Braden’s coworkers. The information provided does not specify their roles in the patent or the extent of their collaboration.
Conclusion
Timothy Michael Braden’s patent describes a fluidized-bed approach to oligonucleotide synthesis that combines resin mixing with strategies for improving washing and reagent efficiency.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
